TY - JOUR AU - Woods, N. F. AU - Mitchell, E. S. PY - 2005 DA - 2005// TI - Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives JO - Am J Med. VL - 118 UR - https://doi.org/10.1016/j.amjmed.2005.09.031 DO - 10.1016/j.amjmed.2005.09.031 ID - Woods2005 ER - TY - JOUR AU - Avis, N. E. AU - Crawford, S. L. AU - Greendale, G. AU - Bromberger, J. T. AU - Everson-Rose, S. A. AU - Gold, E. B. PY - 2015 DA - 2015// TI - Duration of menopausal vasomotor symptoms over the menopause transition JO - JAMA Intern Med VL - 175 UR - https://doi.org/10.1001/jamainternmed.2014.8063 DO - 10.1001/jamainternmed.2014.8063 ID - Avis2015 ER - TY - JOUR AU - Guthrie, J. R. AU - Dennerstein, L. AU - Taffe, J. R. AU - Donnelly, V. PY - 2003 DA - 2003// TI - Health care-seeking for menopausal problems JO - Climacteric VL - 6 UR - https://doi.org/10.1080/cmt.6.2.112.117 DO - 10.1080/cmt.6.2.112.117 ID - Guthrie2003 ER - TY - JOUR AU - Avis, N. E. AU - Colvin, A. AU - Bromberger, J. T. AU - Hess, R. AU - Matthews, K. A. AU - Ory, M. PY - 2009 DA - 2009// TI - Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women’s Health Across the Nation JO - Menopause VL - 16 UR - https://doi.org/10.1097/gme.0b013e3181a3cdaf DO - 10.1097/gme.0b013e3181a3cdaf ID - Avis2009 ER - TY - JOUR AU - Ayers, B. AU - Hunter, M. S. PY - 2013 DA - 2013// TI - Health-related quality of life of women with menopausal hot flushes and night sweats JO - Climacteric VL - 16 UR - https://doi.org/10.3109/13697137.2012.688078 DO - 10.3109/13697137.2012.688078 ID - Ayers2013 ER - TY - JOUR AU - Bhattacharya, S. M. AU - Jha, A. PY - 2010 DA - 2010// TI - A comparison of health-related quality of life (HRQOL) after natural and surgical menopause JO - Maturitas VL - 66 UR - https://doi.org/10.1016/j.maturitas.2010.03.030 DO - 10.1016/j.maturitas.2010.03.030 ID - Bhattacharya2010 ER - TY - JOUR AU - Thurston, R. C. AU - Bromberger, J. T. AU - Joffe, H. AU - Avis, N. E. AU - Hess, R. AU - Crandall, C. J. PY - 2008 DA - 2008// TI - Beyond frequency: who is most bothered by vasomotor symptoms? JO - Menopause VL - 15 UR - https://doi.org/10.1097/gme.0b013e318168f09b DO - 10.1097/gme.0b013e318168f09b ID - Thurston2008 ER - TY - JOUR PY - 2012 DA - 2012// TI - 2012 hormone therapy position statement JO - Menopause. VL - 19 UR - https://doi.org/10.1097/gme.0b013e31824b970a DO - 10.1097/gme.0b013e31824b970a ID - ref8 ER - TY - JOUR AU - Borrelli, F. AU - Ernst, E. PY - 2010 DA - 2010// TI - Alternative and complementary therapies for the menopause JO - Maturitas VL - 66 UR - https://doi.org/10.1016/j.maturitas.2010.05.010 DO - 10.1016/j.maturitas.2010.05.010 ID - Borrelli2010 ER - TY - JOUR AU - Taylor, M. PY - 2015 DA - 2015// TI - Complementary and alternative approaches to menopause JO - Endocrinol Metab Clin North Am VL - 44 UR - https://doi.org/10.1016/j.ecl.2015.05.008 DO - 10.1016/j.ecl.2015.05.008 ID - Taylor2015 ER - TY - JOUR AU - Gartoulla, P. AU - Davis, S. R. AU - Worsley, R. AU - Bell, R. J. PY - 2015 DA - 2015// TI - Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40-65 years JO - Med J Aus VL - 203 UR - https://doi.org/10.5694/mja14.01723 DO - 10.5694/mja14.01723 ID - Gartoulla2015 ER - TY - JOUR AU - Gentry-Maharaj, A. AU - Karpinskyj, C. AU - Glazer, C. AU - Burnell, M. AU - Ryan, A. AU - Fraser, L. PY - 2015 DA - 2015// TI - Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study JO - Menopause VL - 22 UR - https://doi.org/10.1097/GME.0000000000000330 DO - 10.1097/GME.0000000000000330 ID - Gentry-Maharaj2015 ER - TY - STD TI - National Center for Complementary and Integrative Health. Complementary, alternative, or integrative health: what’s in a name? Available at: https://nccih.nih.gov/health/integrative-health. Accessed 10 Mar 2016. UR - https://nccih.nih.gov/health/integrative-health ID - ref13 ER - TY - BOOK AU - Grant, M. D. AU - Marbella, A. AU - Wang, A. T. AU - Pines, E. AU - Hoag, J. AU - Bonnell, C. PY - 2015 DA - 2015// TI - Menopausal symptoms: comparative effectiveness of therapies. Comparative Effectiveness Review No. 147 PB - Agency for Healthcare Research and Quality CY - Rockville, MD ID - Grant2015 ER - TY - STD TI - [No authors listed]. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015;22(11):1155-74. doi:10.1097/gme.0000000000000546. ID - ref15 ER - TY - STD TI - PROSPERO. International prospective register of systematic reviews. #CRD42016029335. Available at: http://www.crd.york.ac.uk/prospero/. Accessed 25 Jan 2016. UR - http://www.crd.york.ac.uk/prospero/ ID - ref16 ER - TY - STD TI - Becker LA, Oxman AD. Chapter 22: overviews of reviews. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org. Accessed 21 Oct 2015 ID - ref17 ER - TY - STD TI - Agency for Healthcare Research and Quality. Methods guide for effectiveness and comparative effectiveness reviews. Rockville, MD: Agency for Healthcare Research and Quality. Available at: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=318. Accessed 16 July 2015. UR - http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=318 ID - ref18 ER - TY - JOUR AU - Joffe, H. AU - Guthrie, K. A. AU - LaCroix, A. Z. AU - Reed, S. D. AU - Ensrud, K. E. AU - Manson, J. E. PY - 2014 DA - 2014// TI - Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial JO - JAMA Intern Med VL - 174 UR - https://doi.org/10.1001/jamainternmed.2014.1891 DO - 10.1001/jamainternmed.2014.1891 ID - Joffe2014 ER - TY - JOUR AU - Harlow, S. D. AU - Gass, M. AU - Hall, J. E. AU - Lobo, R. AU - Maki, P. AU - Rebar, R. W. PY - 2012 DA - 2012// TI - Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging JO - J Clin Endocrinol Metab VL - 97 UR - https://doi.org/10.1210/jc.2011-3362 DO - 10.1210/jc.2011-3362 ID - Harlow2012 ER - TY - STD TI - U.S. Food and Drug Administration. Guidance for industry: estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms—recommendations for clinical evaluation. (Draft guidance from the Center for Drug Evaluation and Research (CDER), January 2003). Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM135338.pdf. Accessed 27 Jan 2016. UR - http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM135338.pdf ID - ref21 ER - TY - JOUR AU - Robinson, K. A. AU - Chou, R. AU - Berkman, N. D. AU - Newberry, S. J. AU - Fu, R. AU - Hartling, L. PY - 2016 DA - 2016// TI - Twelve recommendations for integrating existing systematic reviews into new reviews: EPC guidance JO - J Clin Epidemiol VL - 70 UR - https://doi.org/10.1016/j.jclinepi.2015.05.035 DO - 10.1016/j.jclinepi.2015.05.035 ID - Robinson2016 ER - TY - JOUR AU - Katon, J. G. AU - Gray, K. E. AU - Gerber, M. R. AU - Harrington, L. B. AU - Woods, N. F. AU - Weitlauf, J. C. PY - 2016 DA - 2016// TI - Vasomotor symptoms and quality of life among Veteran and non-Veteran postmenopausal women JO - Gerontologist VL - 56 UR - https://doi.org/10.1093/geront/gnv104 DO - 10.1093/geront/gnv104 ID - Katon2016 ER - TY - JOUR AU - Shin, H. AU - Shin, H. S. PY - 2012 DA - 2012// TI - Measurement of quality of life in menopausal women: a systematic review JO - West J Nurs Res VL - 34 UR - https://doi.org/10.1177/0193945911402848 DO - 10.1177/0193945911402848 ID - Shin2012 ER - TY - STD TI - U.S. Food and Drug Administration. What is a serious adverse event? Available at: http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm. Accessed 28 Oct 2015. UR - http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm ID - ref25 ER - TY - JOUR AU - Brown, J. AU - Farquhar, C. PY - 2014 DA - 2014// TI - Endometriosis: an overview of Cochrane Reviews JO - Cochrane Database Syst Rev VL - 3 ID - Brown2014 ER - TY - JOUR AU - Whiting, P. AU - Savovic, J. AU - Higgins, J. P. AU - Caldwell, D. M. AU - Reeves, B. C. AU - Shea, B. PY - 2016 DA - 2016// TI - ROBIS: a new tool to assess risk of bias in systematic reviews was developed JO - J Clin Epidemiol VL - 69 UR - https://doi.org/10.1016/j.jclinepi.2015.06.005 DO - 10.1016/j.jclinepi.2015.06.005 ID - Whiting2016 ER - TY - JOUR AU - Shea, B. J. AU - Grimshaw, J. M. AU - Wells, G. A. AU - Boers, M. AU - Andersson, N. AU - Hamel, C. PY - 2007 DA - 2007// TI - Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews JO - BMC Med. Res. Methodol. VL - 7 UR - https://doi.org/10.1186/1471-2288-7-10 DO - 10.1186/1471-2288-7-10 ID - Shea2007 ER - TY - JOUR AU - Guyatt, G. AU - Oxman, A. D. AU - Akl, E. A. AU - Kunz, R. AU - Vist, G. AU - Brozek, J. PY - 2011 DA - 2011// TI - GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables JO - J Clin Epidemiol VL - 64 UR - https://doi.org/10.1016/j.jclinepi.2010.04.026 DO - 10.1016/j.jclinepi.2010.04.026 ID - Guyatt2011 ER - TY - JOUR AU - Higgins, J. P. T. AU - Altman, D. G. AU - Gøtzsche, P. C. AU - Jüni, P. AU - Moher, D. AU - Oxman, A. D. PY - 2011 DA - 2011// TI - The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d5928 DO - 10.1136/bmj.d5928 ID - Higgins2011 ER -